{"count": 46, "results": [{"_id": "37111264", "pmid": 37111264, "pmcid": "PMC10144141", "title": "Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus", "journal": "Pharmaceuticals (Basel)", "authors": ["Yu JM", "Chen WM", "Chen M", "Shia BC", "Wu SY"], "date": "2023-03-29T00:00:00Z", "doi": "10.3390/ph16040507", "meta_date_publication": "2023 Mar 29", "meta_volume": "16", "meta_issue": "4", "meta_pages": "", "score": 50257.426, "text_hl": "Association of All-Cause @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@Mortality@@@ with Different Statin Dosages and Classes", "citations": {"NLM": "Yu JM, Chen WM, Chen M, Shia BC, Wu SY. Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus Pharmaceuticals (Basel). 2023 Mar 29;16(4):. PMID: 37111264", "BibTeX": "@article{37111264, title={Effects of Statin Dose, Class, and Use Intensity on All-Cause Mortality in Patients with Type 2 Diabetes Mellitus}, author={Yu JM and Chen WM and Chen M and Shia BC and Wu SY}, journal={Pharmaceuticals (Basel)}, volume={16}, number={4}}"}}, {"_id": "35830548", "pmid": 35830548, "title": "Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.", "journal": "J Clin Gastroenterol", "authors": ["Zhang H", "Zhang Q", "Li S", "Xie B"], "date": "2022-09-01T00:00:00Z", "doi": "10.1097/MCG.0000000000001732", "meta_date_publication": "2022 Sep 1", "meta_volume": "56", "meta_issue": "8", "meta_pages": "e303-e312", "score": 50254.83, "text_hl": "Four studies revealed the impact of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @SPECIES_9606 @@@patient@@@ mortality, with the overall @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ rate found to be significantly lower in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ relative to the control group [risk ratio (RR): 0.46; 95% confidence interval (CI), 0.29 to 0.73; P <0.01]. ", "citations": {"NLM": "Zhang H, Zhang Q, Li S, Xie B. Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis. J Clin Gastroenterol. 2022 Sep 1;56(8):e303-e312. PMID: 35830548", "BibTeX": "@article{35830548, title={Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.}, author={Zhang H and Zhang Q and Li S and Xie B}, journal={J Clin Gastroenterol}, volume={56}, number={8}, pages={e303-e312}}"}}, {"_id": "33846297", "pmid": 33846297, "pmcid": "PMC8041862", "title": "Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles", "journal": "Cell Death Dis", "authors": ["Bai L", "Wang Y", "Huo J", "Li S", "Wen Y", "Liu Q", "Yang J", "Liu Y", "Li R"], "date": "2021-04-12T00:00:00Z", "doi": "10.1038/s41419-021-03669-w", "meta_date_publication": "2021 Apr 12", "meta_volume": "12", "meta_issue": "4", "meta_pages": "392", "score": 50253.37, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ accelerated @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@motoneurons death@@@ in @CELLLINE_CVCL:C0CZ @@@SOD1G93A@@@ @SPECIES_10090 @@@mice@@@ through inhibiting @GENE_RAB7 @GENE_19349 @@@Rab7@@@-mediated maturation of late autophagic vacuoles", "citations": {"NLM": "Bai L, Wang Y, Huo J, Li S, Wen Y, Liu Q, Yang J, Liu Y, Li R. Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles Cell Death Dis. 2021 Apr 12;12(4):392. PMID: 33846297", "BibTeX": "@article{33846297, title={Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles}, author={Bai L and Wang Y and Huo J and Li S and Wen Y and Liu Q and Yang J and Liu Y and Li R}, journal={Cell Death Dis}, volume={12}, number={4}, pages={392}}"}}, {"_id": "32872631", "pmid": 32872631, "pmcid": "PMC7503978", "title": "Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type", "journal": "Int J Environ Res Public Health", "authors": ["Kim J", "Kim HS", "Yang W", "Lee JW", "Kang HT"], "date": "2020-08-30T00:00:00Z", "doi": "10.3390/ijerph17176309", "meta_date_publication": "2020 Aug 30", "meta_volume": "17", "meta_issue": "17", "meta_pages": "", "score": 50252.137, "text_hl": "If a @SPECIES_9606 @@@patient@@@ experienced either @DISEASE_Disease @DISEASE_MESH:D004194 @@@CCVDs@@@ or related @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@deaths@@@, that day was the end date of the study. ", "citations": {"NLM": "Kim J, Kim HS, Yang W, Lee JW, Kang HT. Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type Int J Environ Res Public Health. 2020 Aug 30;17(17):. PMID: 32872631", "BibTeX": "@article{32872631, title={Primary Prevention of Cardiocerebrovascular Diseases and Related Deaths According to Statin Type}, author={Kim J and Kim HS and Yang W and Lee JW and Kang HT}, journal={Int J Environ Res Public Health}, volume={17}, number={17}}"}}, {"_id": "33771685", "pmid": 33771685, "pmcid": "PMC8422958", "title": "SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation", "journal": "Contemp Clin Trials", "authors": ["Kaplan DE", "Mehta R", "Garcia-Tsao G", "Albrecht J", "Aytaman A", "Baffy G", "Bajaj J", "Hernaez R", "Hunt K", "Ioannou G", "Johnson K", "Kanwal F", "Lee TH", "Monto A", "Pandya P", "Schaubel D", "Taddei TH"], "date": "2021-05-01T00:00:00Z", "doi": "10.1016/j.cct.2021.106367", "meta_date_publication": "2021 May", "meta_volume": "104", "meta_issue": "", "meta_pages": "106367", "score": 50247.805, "text_hl": "SACRED: Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@hepatic decompensation@@@ and @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ in subjects with high-risk compensated @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cirrhosis@@@: Statins and @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@Cirrhosis@@@: Reducing Events of Decompensation", "citations": {"NLM": "Kaplan DE, Mehta R, Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G, Bajaj J, Hernaez R, Hunt K, Ioannou G, Johnson K, Kanwal F, Lee TH, Monto A, Pandya P, Schaubel D, Taddei TH. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation Contemp Clin Trials. 2021 May;104():106367. PMID: 33771685", "BibTeX": "@article{33771685, title={SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation}, author={Kaplan DE and Mehta R and Garcia-Tsao G and Albrecht J and Aytaman A and Baffy G and Bajaj J and Hernaez R and Hunt K and Ioannou G and Johnson K and Kanwal F and Lee TH and Monto A and Pandya P and Schaubel D and Taddei TH}, journal={Contemp Clin Trials}, volume={104}, pages={106367}}"}}, {"_id": "37010535", "pmid": 37010535, "title": "Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.", "journal": "Eur J Clin Pharmacol", "authors": ["Yu JM", "Chen WM", "Shia BC", "Wu SY"], "date": "2023-05-01T00:00:00Z", "doi": "10.1007/s00228-023-03488-2", "meta_date_publication": "2023 May", "meta_volume": "79", "meta_issue": "5", "meta_pages": "687-700", "score": 50246.47, "text_hl": "The priority of protective effects on @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@mortality@@@ are @CHEMICAL_pitavastatin @CHEMICAL_MESH:C108475 @@@pitavastatin@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@, and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ for the statin users compared with non-statin users.", "citations": {"NLM": "Yu JM, Chen WM, Shia BC, Wu SY. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study. Eur J Clin Pharmacol. 2023 May;79(5):687-700. PMID: 37010535", "BibTeX": "@article{37010535, title={Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.}, author={Yu JM and Chen WM and Shia BC and Wu SY}, journal={Eur J Clin Pharmacol}, volume={79}, number={5}, pages={687-700}}"}}, {"_id": "40736696", "pmid": 40736696, "title": "Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.", "journal": "Am J Gastroenterol", "authors": ["Rana R", "Tabish M", "Agarwal S", "Bayye R", "Ahmed S", "Gunjan D", "Sharma S", "Saraya A"], "date": "2025-07-31T00:00:00Z", "doi": "10.14309/ajg.0000000000003689", "meta_date_publication": "2025 Jul 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.227, "text_hl": "Twenty-four @SPECIES_9606 @@@patients@@@(18%) on @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 44(31%) on standard therapy @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@died@@@ over follow-up[hazard-ratio(HR) for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@: 0.48[95%CI:0.29-0.81;p=0.006) with similar results on intention to treat and on per-protocol analysis(excluding 17 @SPECIES_9606 @@@patients@@@ who stopped @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@). ", "citations": {"NLM": "Rana R, Tabish M, Agarwal S, Bayye R, Ahmed S, Gunjan D, Sharma S, Saraya A. Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial. Am J Gastroenterol. 2025 Jul 31;():. PMID: 40736696", "BibTeX": "@article{40736696, title={Simvastatin addition to standard of care improves long-term survival in patients with cirrhosis after variceal bleed: An open label randomized controlled trial.}, author={Rana R and Tabish M and Agarwal S and Bayye R and Ahmed S and Gunjan D and Sharma S and Saraya A}, journal={Am J Gastroenterol}}"}}, {"_id": "33497862", "pmid": 33497862, "title": "LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.", "journal": "Atherosclerosis", "authors": ["Vallejo-Vaz AJ", "Packard CJ", "Ference BA", "Santos RD", "Kastelein JJP", "Stein EA", "Catapano AL", "Pedersen TR", "Watts GF", "Ray KK"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2021.01.003", "meta_date_publication": "2021 Mar", "meta_volume": "320", "meta_issue": "", "meta_pages": "1-9", "score": 50241.367, "text_hl": "RESULTS: 2267 and 2164 participants had LDL-C <4.9 and >= 4.9 mmol/L, respectively. @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@Mortality@@@ endpoints and major coronary events (MCE) were significantly reduced with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ versus placebo in both groups over 5.4 years, but the latter derived greater absolute risk reductions (ARR) (4.1-4.3% for @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@mortality@@@ endpoints, versus 2.5-2.8%). ", "citations": {"NLM": "Vallejo-Vaz AJ, Packard CJ, Ference BA, Santos RD, Kastelein JJP, Stein EA, Catapano AL, Pedersen TR, Watts GF, Ray KK. LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial. Atherosclerosis. 2021 Mar;320():1-9. PMID: 33497862", "BibTeX": "@article{33497862, title={LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.}, author={Vallejo-Vaz AJ and Packard CJ and Ference BA and Santos RD and Kastelein JJP and Stein EA and Catapano AL and Pedersen TR and Watts GF and Ray KK}, journal={Atherosclerosis}, volume={320}, pages={1-9}}"}}, {"_id": "38417300", "pmid": 38417300, "title": "Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry.", "journal": "Thromb Res", "authors": ["Siniscalchi C", "Bikdeli B", "Jiménez D", "Suriñach JM", "Demelo-Rodríguez P", "Moustafa F", "Gil-Díaz A", "García-Ortega A", "Bui HM", "Monreal M", "RIETE Investigators"], "date": "2024-02-24T00:00:00Z", "doi": "10.1016/j.thromres.2024.02.024", "meta_date_publication": "2024 Feb 24", "meta_volume": "236", "meta_issue": "", "meta_pages": "88-96", "score": 50229.027, "text_hl": "The 3-month risk of @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@ in statin users was significantly lower than in non-users in @SPECIES_9606 @@@patients@@@ with upper-limb @DISEASE_Venous_Thrombosis @DISEASE_MESH:D020246 @@@DVT@@@ (aHR: 0.81; 95%CI: 0.72-0.91), distal lower-limb @DISEASE_Venous_Thrombosis @DISEASE_MESH:D020246 @@@DVT@@@ (aHR: 0.48; 95%CI: 0.32-0.72), or proximal lower-limb @DISEASE_Venous_Thrombosis @DISEASE_MESH:D020246 @@@DVT@@@ (aHR: 0.69; 95%CI: 0.50-0.95), and in those receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (aHR: 0.73; 95%CI: 0.60-0.90), @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (aHR: 0.70; 95%CI: 0.59-0.85), or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ (aHR: 0.47; 95%CI: 0.27-0.80). ", "citations": {"NLM": "Siniscalchi C, Bikdeli B, Jiménez D, Suriñach JM, Demelo-Rodríguez P, Moustafa F, Gil-Díaz A, García-Ortega A, Bui HM, Monreal M, RIETE Investigators. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry. Thromb Res. 2024 Feb 24;236():88-96. PMID: 38417300", "BibTeX": "@article{38417300, title={Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry.}, author={Siniscalchi C and Bikdeli B and Jiménez D and Suriñach JM and Demelo-Rodríguez P and Moustafa F and Gil-Díaz A and García-Ortega A and Bui HM and Monreal M and RIETE Investigators}, journal={Thromb Res}, volume={236}, pages={88-96}}"}}, {"_id": "36065271", "pmid": 36065271, "pmcid": "PMC9440634", "title": "Inhibition of Delayed Cerebral Ischemia by Magnesium Is Insufficient for Subarachnoid Hemorrhage Patients: A Network Meta-Analysis", "journal": "Evid Based Complement Alternat Med", "authors": ["Ba XH", "Wang XD", "Dai YY"], "date": "2022-08-26T00:00:00Z", "doi": "10.1155/2022/9357726", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "9357726", "score": 50223.67, "text_hl": "In the network meta-analysis, @CHEMICAL_Magnesium @CHEMICAL_MESH:D008274 @@@magnesium@@@ plus @CHEMICAL_Nimodipine @CHEMICAL_MESH:D009553 @@@nimodipine@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ even showed an effective trend in @<m>DISEASE_Death</m> @DISEASE_MESH:D003643 @@@death@@@/persistent vegetative status improvement. ", "citations": {"NLM": "Ba XH, Wang XD, Dai YY. Inhibition of Delayed Cerebral Ischemia by Magnesium Is Insufficient for Subarachnoid Hemorrhage Patients: A Network Meta-Analysis Evid Based Complement Alternat Med. 2022;2022():9357726. PMID: 36065271", "BibTeX": "@article{36065271, title={Inhibition of Delayed Cerebral Ischemia by Magnesium Is Insufficient for Subarachnoid Hemorrhage Patients: A Network Meta-Analysis}, author={Ba XH and Wang XD and Dai YY}, journal={Evid Based Complement Alternat Med}, volume={2022}, pages={9357726}}"}}]}